InMed is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.
Read more
InMed to Present at the 8th Annual LD Micro Invitational Conference
